Gen-Wealth Partners’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.4K Buy
+63
New +$32.6K 0.01% 461
2025
Q1
– Sell
-220
Closed -$77.6K – 666
2024
Q4
$77.6K Hold
220
– – 0.03% 318
2024
Q3
$79.5K Buy
+220
New +$74.3K 0.03% 318

Other funds holding UTHR

Gen-Wealth Partners's UTHR Position: Q3 2026 in Review

Gen-Wealth Partners opened a new position in United Therapeutics (UTHR) in Q3 2026: 63 shares worth $34.4K. The stake represents 0.01% of the portfolio and ranks #461 among its holdings. This is a return to the name: Gen-Wealth Partners previously reported a position in UTHR as recently as Q4 2024.

Gen-Wealth Partners first reported a position in UTHR in Q3 2024 and has held it in 3 quarters since. The position peaked at $79.5K in Q3 2024. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Gen-Wealth Partners held 63 shares of United Therapeutics worth $34.4K as of Q3 2026.
  • United Therapeutics was a new Gen-Wealth Partners position in Q3 2026.
  • United Therapeutics made up 0.01% of Gen-Wealth Partners's portfolio in Q3 2026, its #461 holding.
  • Gen-Wealth Partners first reported a position in United Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Gen-Wealth Partners's United Therapeutics position peaked at $79.5K in Q3 2024.
  • 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Gen-Wealth Partners's 13F filing for Q3 2026, filed 4 Nov 2026.